Global venture capital firm Eight Roads Ventures has launched a US$250M China Healthcare Fund.
The fund builds on Eight Roads’ global focus on healthcare and technology and reflects the size of the market opportunity in China. being driven by an ageing population, increasing patient demands, the yet-to-improved healthcare payment system, and ambitious policy reforms supported by the Chinese Government.
Led by Daniel Auerbach, Senior Managing Partner, Asia, China Healthcare Fund will concentrate on four investment areas: Therapeutics, Healthcare Services, Healthcare IT/Digital Health, and MedTec. 40% of the fund’s allocation will be in therapeutics. Eight Roads invests not only in existing companies but will continue to found new ventures to tackle unmet market demand, and intransigent health and delivery issues.
A dedicated Eight Roads China technology fund is also in the pipeline.